Published in Eur J Cancer on August 01, 2003
Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 11.96
Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ (2006) 5.82
Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study. Lancet Oncol (2015) 4.60
Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res (2005) 2.81
Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res (2005) 2.67
Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer (2004) 1.85
Overdiagnosis and overtreatment of breast cancer: overdiagnosis and overtreatment in service screening. Breast Cancer Res (2005) 1.12
Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast. Ann Surg Oncol (2007) 1.03
Arguments against mammography screening continue to be based on faulty science. Oncologist (2014) 1.00
Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: a pilot study. Breast Cancer Res (2009) 0.99
Beyond the mammography debate: a moderate perspective. Curr Oncol (2015) 0.97
Breast screening has increased the number of mastectomies. Breast Cancer Res (2009) 0.85
Overdiagnosis: epidemiologic concepts and estimation. Epidemiol Health (2015) 0.84
Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom. Breast Cancer Res (2012) 0.82
Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom. Br J Cancer (2014) 0.80
Mammary cancer initiation and progression studied with magnetic resonance imaging. Breast Cancer Res (2014) 0.79
Pitfalls in accurate estimation of overdiagnosis: implications for screening policy and compliance. Breast Cancer Res (2013) 0.77
The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening. Breast Cancer Res (2016) 0.76
The pitfalls of lung cancer screening. Cancer Imaging (2004) 0.75
Rethinking: Ideal Screening Age for Breast Cancer in Developing Countries. J Breast Health (2013) (2015) 0.75
Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review. J Med Screen (2016) 0.75
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer (2001) 6.16
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health (1989) 5.20
Overlapping genes at the cheA locus of Escherichia coli. Proc Natl Acad Sci U S A (1980) 4.82
Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am (1992) 4.34
Breast cancer treatment and natural history: new insights from results of screening. Lancet (1992) 3.77
A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet (2000) 3.76
Two classes of PDGF receptor recognize different isoforms of PDGF. Science (1988) 3.59
The natural history of breast carcinoma: what have we learned from screening? Cancer (1999) 3.55
Dietary effects on breast-cancer risk in Singapore. Lancet (1991) 3.32
Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer (1995) 3.32
The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am (2000) 3.18
The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer (2007) 3.15
Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem (2000) 3.12
Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF. EMBO J (1993) 3.11
American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin (1997) 2.89
The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer (1997) 2.75
Genomic 5-methyldeoxycytidine decreases with age. J Biol Chem (1987) 2.74
Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J (1995) 2.73
Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy. Nature (1981) 2.71
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen (2004) 2.62
Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61
Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut (1983) 2.53
Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med (2001) 2.47
Early onset of breast cancer in a group of British black women. Br J Cancer (2008) 2.47
Increasing physician productivity and the hospitalization characteristics of practices using Medex. A progress report. Northwest Med (1971) 2.34
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer (2011) 2.28
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology (2004) 2.26
The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem Biophys Res Commun (1979) 2.26
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer (2003) 2.24
Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr (1997) 2.24
Probing proton dynamics in molecules on an attosecond time scale. Science (2006) 2.24
Lymphedema: current issues in research and management. CA Cancer J Clin (2000) 2.21
Pressure support ventilation decreases inspiratory work of breathing during general anesthesia and spontaneous ventilation. Anesth Analg (1992) 2.14
Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer (1995) 2.13
Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden. Diagn Imaging Clin Med (1985) 2.02
Ribonucleic acid-protein fractions of virulent Salmonella typhimurium as protective immunogens. Infect Immun (1972) 1.99
Infiltrating lobular carcinoma of the breast. Histopathology (1982) 1.98
A study guided by the Health Belief Model of the predictors of breast cancer screening of women ages 40 and older. Public Health Rep (1991) 1.97
Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study. BMJ (1999) 1.96
Determination of inorganic phosphate in the presence of labile organic phosphates. Anal Biochem (1969) 1.89
The active form of tumor necrosis factor is a trimer. J Biol Chem (1987) 1.86
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer (2013) 1.85
Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res (1996) 1.84
Planning for the future: the experience of implementing a children's day assessment unit in a district general hospital. Arch Dis Child (1997) 1.83
Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev (2000) 1.82
A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen (2004) 1.81
A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol (2007) 1.80
Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening. Eur J Cancer Clin Oncol (1987) 1.79
The pressure reversal of general anesthesia and the critical volume hypothesis. Mol Pharmacol (1973) 1.79
Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin (1997) 1.75
Intranasal Teeth. Report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol (1979) 1.73
Pre- and postnatal choline supplementation produces long-term facilitation of spatial memory. Dev Psychobiol (1988) 1.72
Effect of breast cancer screening after age 65. J Med Screen (1995) 1.69
Comparing the quality of death for hospice and non-hospice cancer patients. Med Care (1988) 1.67
Hemodynamic and gas exchange alterations during Intralipid infusion in patients with adult respiratory distress syndrome. Chest (1989) 1.66
Detection of delayed hypersensitivity in mice injected with ribonucleic acid-protein fractions of Salmonella typhimurium. Infect Immun (1972) 1.64
Methionine synthesis from 5'-methylthioadenosine in rat liver. J Biol Chem (1981) 1.63
UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax (2011) 1.62
Expression of calf prochymosin in Saccharomyces cerevisiae. Gene (1984) 1.61
Multi-state Markov models in cancer screening evaluation: a brief review and case study. Stat Methods Med Res (2010) 1.60
Heterologous protein secretion from yeast. Science (1985) 1.58
Pickled vegetables in the aetiology of oesophageal cancer in Hong Kong Chinese. Lancet (1992) 1.56
Expression cloning and signaling properties of the rat glucagon receptor. Science (1993) 1.54
Comparison of single reading with double reading of mammograms, and change in effectiveness with experience. Br J Radiol (1995) 1.54
Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches. Am J Epidemiol (1998) 1.54
Physicochemical approaches to the mode of action of general anesthetics. Anesthesiology (1972) 1.53
Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br J Surg (2000) 1.51
Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer (1989) 1.51
Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Ann Oncol (1997) 1.51
Cystic ameloblastoma--behavior and treatment of 21 cases. J Oral Maxillofac Surg (2001) 1.51
Correction of risk estimates for measurement error in epidemiology. Methods Inf Med (1995) 1.50
Techniques in the detection and characterization of phosphoramidate-containing proteins. Methods Enzymol (1984) 1.50
Factors related to cervicitis in Qashghaee nomadic women of southern Iran. Rev Epidemiol Sante Publique (1997) 1.49
Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986). Int J Epidemiol (1991) 1.49
Escherichia coli O157 in feedlot cattle feces and water in four major feeder-cattle states in the USA. Prev Vet Med (2003) 1.49
American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin (1997) 1.48
The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc Natl Acad Sci U S A (1974) 1.48
Repeat measurement of case-control data: correcting risk estimates for misclassification due to regression dilution of lipids in transient ischemic attacks and minor ischemic strokes. Am J Epidemiol (1991) 1.47
Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer (1997) 1.46
Acrolein initiates rat urinary bladder carcinogenesis. Cancer Res (1992) 1.45
NMR analysis of main-chain conformational preferences in an unfolded fibronectin-binding protein. J Mol Biol (1997) 1.45
Breast cancer in Singapore: trends in incidence 1968-1992. Int J Epidemiol (1996) 1.41
Direct demonstration of retroviral recombination in a rhesus monkey. J Virol (1997) 1.41
Intermittent CPAP: a new mode of ventilation during general anesthesia. Anesthesiology (1998) 1.41
The Tabár classification of mammographic parenchymal patterns. Eur J Radiol (1997) 1.40
A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg (2008) 1.40
Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors. J Biol Chem (1986) 1.40
Socioeconomic effects on breast cancer survival: proportion attributable to stage and morphology. Br J Cancer (2003) 1.40